Health
Researchers urge delaying Pfizer vaccine’s second dose as first highly effective – Reuters
The second dose of Pfizer Inc’s COVID-19 vaccine could be delayed in order to cover all priority groups as the first one is highly protective, two Canada-based…
By Reuters Staff
(Reuters) – The second dose of Pfizer Incs COVID-19 vaccine could be delayed in order to cover all priority groups as the first one is highly protective, two Canada-based researchers said in a letter published in the New England Journal of Medicine.
The vaccine had an efficacy of 92.6% after the first dose, Danuta Skowronski and Gaston De Serres said, based on an analysis of the documents submitted by the drugmaker to the U.S. Food and Drug Administration (FDA).
These findings were…
-
Noosa News23 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News22 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News19 hours agoGyrocopter pilot injured in crash-landing on K’Gari, north of Brisbane
-
General21 hours agoTyler Wright soaks up Bells Beach return as poor conditions at Rip Curl Pro sees men’s opening round called off